Categories AlphaGraphs, Earnings, Health Care
Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today.
Reported sales increased 5.8% year-over-year to $23.7 billion. Operational sales growth was 4.6%.
Net earnings grew over 18% to $5.5 billion, or $2.29 per share, compared to last year. Adjusted EPS dropped 1.8% to $2.77.
Revenue and earnings beat expectations.
The company saw sales in the US increase 7.8% to $13.5 billion while international sales grew 3.2% to $10.2 billion.
Sales in the Innovative Medicine segment rose 4.9% to $15.2 billion while sales in the MedTech segment increased 7.3% to $8.5 billion.
For full-year 2025, JNJ expects reported sales to range between $93.2-93.6 billion while adjusted EPS is expected to be $10.80-10.90.
The stock gained 2% in premarket hours on Wednesday.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
